LTFS
PVLA

Ladenburg Thalmann Financial Services’s Palvella Therapeutics PVLA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8
Closed -$2.22K – 5243
2019
Q3 		$2K Buy
+8
New +$3.1K ﹤0.01% 5017
2018
Q4 		– Sell
-8
Closed -$3K – 5361
2018
Q3 		$3K Hold
8
– – ﹤0.01% 4803
2018
Q2 		$4K Hold
8
– – ﹤0.01% 4696
2018
Q1 		$4K Buy
+8
New +$4.95K ﹤0.01% 4696

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PVLA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services sold out of Palvella Therapeutics (PVLA) in Q4 2019, closing a stake of 8 shares — an estimated $2.22K sold.

Ladenburg Thalmann Financial Services first reported a position in PVLA in Q1 2018 and held it in 4 quarters. The position peaked at $4K in Q2 2018. 97 funds tracked by Wall St. Rank hold PVLA as of Q4 2019.

  • Ladenburg Thalmann Financial Services reported no remaining Palvella Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 8 Palvella Therapeutics shares in Q4 2019, an estimated $2.22K.
  • Ladenburg Thalmann Financial Services first reported a position in Palvella Therapeutics in Q1 2018 and held it in 4 quarters.
  • Ladenburg Thalmann Financial Services's Palvella Therapeutics position peaked at $4K in Q2 2018.
  • 97 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.